760947-20-4
760947-20-4
Chemical Structure
Aminopeptidase N Ligand (CD13) NGR peptide
- CAS No.: 760947-20-4
- Formula:C20H34N10O8S2
- Molecular Weight:606.68
InChIKey: DVIDAVXQSLGAQG-BJDJZHNGSA-N
SMILES: N=C(N)NCCC[C@H]1C(N[C@@H](CSSC[C@@H](C(N[C@H](C(NCC(N1)=O)=O)CC(N)=O)=O)N)C(NCC(O)=O)=O)=O
Biological Activity: Aminopeptidase N Ligand (CD13) NGR peptide is a polypeptide targeting CD13 and can be used as a carrier to mediate intracellular transmission. Aminopeptidase N Ligand (CD13) NGR peptide is often used in cancer research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Aminopeptidase N Ligand (CD13) NGR peptide | 99.54% | Aminopeptidase N Ligand (CD13) NGR peptide is a polypeptide targeting CD13 and can be used as a carrier to mediate intracellular transmission. Aminopeptidase N Ligand (CD13) NGR peptide is often used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Liu C, et al. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis. J Control Release. 2011 Apr 30;151(2):162-75. [Content Brief]
- [2]. Curnis F, et al. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol. 2000 Nov;18(11):1185-90. [Content Brief]
